PubRank

Isao Matsui

Author PubWeight™ 25.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 2011 2.04
2 The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. J Am Soc Nephrol 2009 1.95
3 Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis. Bone 2012 1.62
4 Autophagy guards against cisplatin-induced acute kidney injury. Am J Pathol 2012 1.56
5 Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 2004 1.35
6 Combined use of vitamin D status and FGF23 for risk stratification of renal outcome. Clin J Am Soc Nephrol 2012 1.16
7 Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 2010 1.08
8 Use of xanthine oxidase inhibitor febuxostat inhibits renal interstitial inflammation and fibrosis in unilateral ureteral obstructive nephropathy. Clin Exp Nephrol 2012 0.99
9 The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone 2009 0.98
10 Micro-emulsion synthesis of monodisperse surface stabilized silicon nanocrystals. Chem Commun (Camb) 2005 0.97
11 Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3. Lab Invest 2012 0.89
12 Autophagy protects kidney proximal tubule epithelial cells from mitochondrial metabolic stress. Autophagy 2013 0.88
13 A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats. Mol Med 2011 0.86
14 Guideline-practice gap in the management of predialysis chronic kidney disease mineral bone disorder in Japan. Ther Apher Dial 2011 0.85
15 Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone 2008 0.83
16 Vitamin D deficiency predicts decline in kidney allograft function: a prospective cohort study. J Clin Endocrinol Metab 2013 0.82
17 Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone 2012 0.81
18 Negative effects of anemia on quality of life and its improvement by complete correction of anemia by administration of recombinant human erythropoietin in posttransplant patients. Clin Exp Nephrol 2009 0.81
19 Towards developing new strategies to reduce the adverse side-effects of nonsteroidal anti-inflammatory drugs. Clin Exp Nephrol 2011 0.80
20 Urinary type IV collagen in nondiabetic kidney disease. Nephron Clin Pract 2010 0.79
21 Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics. Clin Exp Nephrol 2008 0.79
22 Orally active vitamin d for potential chemoprevention of posttransplant malignancy. Cancer Prev Res (Phila) 2012 0.79
23 Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis. J Bone Miner Metab 2013 0.77
24 Specialist care and improved long-term survival of dialysis patients. Nephrol Dial Transplant 2010 0.77
25 Effects of nicorandil on the reduction of BNP levels in patients with chronic kidney disease. Clin Exp Nephrol 2011 0.77
26 Usefulness of bone resorption markers in hemodialysis patients. Bone 2009 0.76
27 Early plasma exchange for progressive liver failure in recipients of adult-to-adult living-related liver transplants. Blood Purif 2009 0.75
28 [Pulmonary infection of Pneumocystis carinii and Cytomegalo virus in the treatment of cholesterol crystal embolism]. Nihon Jinzo Gakkai Shi 2006 0.75
29 Tranexamic acid-induced visual impairment in a hemodialysis patient. Clin Exp Nephrol 2003 0.75